Skip to Content
August, 8 2022

SteraMist Provides Protection Against Monkeypox and Other Pathogens

Coronavirus Is Not An Outlier In Interconnected Age of Air Travel and Urbanization; TOMI Environmental Partners With Customers To Provide Disinfection and Decontamination Against Growing Frequency of Infectious Disease Outbreaks

TOMI is uniquely prepared to provide effective disinfection solutions for its existing and new customers by ensuring that its SteraMist systems and BIT solution are ready to deploy at a moment’s notice.

TOMI’s integrated business model includes preparedness for any disaster response and unforeseen emergency. TOMI continues to proactively procure all essential components to its products, in spite of the ongoing global supply chain challenges, to ensure its customers and partners can dependably receive uninterrupted access to SteraMist solutions and services.

EPA List Q: Emerging Viral Pathogens (EVP), including Monkeypox

The Environmental Protection Agency (EPA) listed SteraMist Binary Ionization Technology (BIT) on its Emerging Viral Pathogen (EVP) Guidance for Antimicrobial Pesticides, List Q, as an effective disinfectant against the Monkeypox virus. SteraMist BIT received the listing because it has proven efficacy on viruses that are more difficult to kill. The product is validated using Geobacillus stearothermophilus, one of the most resistant microbes, Biological Indicators (BIs) which is universally accepted by several organizations as the “Gold Standard” for monitoring decontamination and sterilization protocols.

Fighting Epidemics and Pandemics

SteraMist is currently deployed throughout hospitals, laboratories, offices, and other facilities worldwide to assist with disinfection against some of the most lethal pathogens on a daily basis. In addition, iHP technology has a long history of successfully combating pathogens causing epidemics and pandemics, including Ebola, MERS-CoV, and SARS-CoV-2. TOMI plans to continue this legacy in the face of unexpected outbreaks, such as the recent spread of Monkeypox virus, which has been declared by the White House as a public health emergency.

SteraMist offers superior advantages

Whether an outbreak or pandemic requires disinfection with fast, no-touch application or decontamination of large-scale areas, SteraMist technology provides uncompromising premium efficacy. From infected office staff passing pathogens to coworkers to foodborne virus moving from surface to product, SteraMist products are positioned to deliver premium disinfection in an oversaturated market of superficial disinfectants and ineffective cleaning methods.

Dr. Shane, CEO of TOMI, stated, “As the world moves beyond the COVID-19 pandemic, a shift has occurred in how the public and business organizations view disinfection as a critical tool in protecting health and safety in social environments. COVID-19 is part of a pattern of an increasing number of outbreaks with globalization and urbanization. People are more concerned with new pathogens and businesses are highly focused on implementing preventive measures to mitigate risks and losses. SteraMist’s quick disinfection process results in a six-log kill with no residue, providing comfort to customers that this product enables them to contend with new pathogens as they arise while maintaining facility integrity and environmental safety. Regardless of the crises, we will always provide consistent quality and maintain solution inventory.” Learn more about the advantages of SteraMist disinfection here.